Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
Rachel H. McMahan(University of Colorado Denver), Hugo R. Rosen(National Jewish Health), Maxwell L. Smith(Mayo Clinic Health System), Tibor I. Krisko(NewYork–Presbyterian Hospital), Xiaoxin X. Wang(Georgetown University), Luciano Adorini(Intercept Pharmaceuticals (United States)), Mark Pruzanski(University of Padua), Lin Cheng(University of Colorado Denver), Moshe Levi, Karim El Kasmi(University of Colorado Denver), Lucy Golden‐Mason(Jewish Hospital)
Cited by 218
Related Papers
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|628